Potential of a New Subgroup D Adenovirus Vector for Vaccination

Potential of a New Subgroup D Adenovirus Vector for Vaccination

Bibliographic Details
Main Authors:	Martin, S, Terry, H, Bridgeman, A, Harris, C, Blair, E, Arnberg, N, Hanke, T, Easton, A, Burgert, H
Format:	Conference item
Published:	2010

Similar Items

Simian adenoviruses as vaccine vectors
by: Morris, S, et al.
Published: (2016)

Simian adenoviruses as vaccine vectors
by: Morris, S, et al.
Published: (2016)

Low seroprevalent species D adenovirus vectors as influenza vaccines.
by: Eric A Weaver, et al.
Published: (2013-01-01)

Novel adenovirus vaccine vectors
by: Dicks, M
Published: (2013)

IL-10 Receptor Blockade Enhances CD4 and CD8 T Cell Responses to a Simian Adenovirus-Vectored HIV-1 Vaccine, ChAdV63.HIVconsv
by: Clutton, G, et al.
Published: (2013)

Special Issue “Adenovirus Pathogenesis”
by: Niklas Arnberg, et al.
Published: (2021-06-01)

Rapid-response manufacturing of adenovirus-vectored vaccines
by: Joe, CCD, et al.
Published: (2023)

Novel Adenovirus Vector-Based Vaccines for HIV
by: Letvin N, et al.
Published: (2005-12-01)

MAIT cell activation augments adenovirus vector vaccine immunogenicity
by: Provine, N, et al.
Published: (2021)

Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method
by: Roy Chad J, et al.
Published: (2011-11-01)

Species D Adenoviruses as Oncolytic Viral Vectors
by: Brianna L. Bullard, et al.
Published: (2020-12-01)

Cytokine Responses to Adenovirus and Adenovirus Vectors
by: Svetlana Atasheva, et al.
Published: (2022-04-01)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
by: Marta Ulaszewska, et al.
Published: (2023-01-01)

Single-cycle adenovirus vectors in the current vaccine landscape
by: Michael Barry
Published: (2018-02-01)

Vector delivery-dependant effect of human tissue plasminogen activator signal peptide on vaccine induction of T cells
by: Hanke, T, et al.
Published: (2016)

Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B.
by: McDermott, MR, et al.
Published: (1989)

Adenovirus vector and mRNA vaccines: mechanisms regulating their immunogenicity
by: Provine, NM, et al.
Published: (2022)

Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
by: Cal Koger-Pease, et al.
Published: (2023-02-01)

Transient foamy virus vector production by adenovirus vectors.
by: Russell, R, et al.
Published: (2004)

Immune responses to adenovirus vectors in the nervous system.
by: Wood, M, et al.
Published: (1996)

Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus Vectors
by: E. P. Kharchenko
Published: (2020-11-01)

Humoral immune responses to adenovirus vectors in the brain.
by: Kajiwara, K, et al.
Published: (2000)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
by: Catherine Collignon, et al.
Published: (2020-11-01)

Role of T cells in inflammation caused by adenovirus vectors in the brain.
by: Byrnes, A, et al.
Published: (1996)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
by: Warimwe, G, et al.
Published: (2013)

Uncovering the mechanisms of adenovirus vector immunogenicity
by: Dicks, M, et al.
Published: (2013)

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.
by: Dudareva, M, et al.
Published: (2009)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
by: Green, C, et al.
Published: (2015)

Evolving Horizons: Adenovirus Vectors’ Timeless Influence on Cancer, Gene Therapy and Vaccines
by: Prasad D. Trivedi, et al.
Published: (2023-12-01)

Pre-Clinical Development of an Adenovirus Vector Based RSV and Shingles Vaccine Candidate
by: Lawrence Petherbridge, et al.
Published: (2023-11-01)

Adenovirus vector-based vaccines as forefront approaches in fighting the battle against flaviviruses
by: Mohammad Shoushtari, et al.
Published: (2022-11-01)

Alpha-defensin 5 differentially modulates adenovirus vaccine vectors from different serotypes in vivo.
by: Lawrence J Tartaglia, et al.
Published: (2019-12-01)

Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.
by: Aseem Pandey, et al.
Published: (2012-01-01)

Immunogenicity in mice of tandem repeats of an epitope from herpes simplex gD protein when expressed by recombinant adenovirus vectors.
by: Zheng, B, et al.
Published: (1993)

Adenovirus-vectored vaccine containing multidimensionally conserved parts of the HIV proteome is immunogenic in rhesus macaques
by: Murakowski, Dariusz K, et al.
Published: (2021)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
by: Dicks, M, et al.
Published: (2011)

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
by: O'Hara, G, et al.
Published: (2012)

Myocarditis following AstraZeneca (an adenovirus vector vaccine) COVID‐19 vaccination: A case report
by: Shakiba Hassanzadeh, et al.
Published: (2022-04-01)

First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.
by: Kathryn E Stephenson, et al.
Published: (2018-01-01)

Adenovirus-vectored immunocontraception in rat model
by: Lo, Sewn Cen
Published: (2012)